COYA

Coya Therapeutics Stock Analysis

AI Rating

Low
  • Quality5/10
  • Growth↓ 0/10
  • Momentum↓ 2/10
Coya Therapeutics sales and earnings growth
COYA Growth
Low
  • Revenue Y/Y↓ -58.26%
  • EPS Y/Y↓ -70.77%
  • FCF Y/Y↓ -19.98%
Coya Therapeutics gross and profit margin trends
COYA Profitability
Low
  • Gross margin ↑ 100.00%
  • EPS margin↓ -462.30%
  • ROIC↓ -49060.60%
Coya Therapeutics net debt vs free cash flow
COYA Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Coya Therapeutics stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗